| Trial Identifier: | 6482-013 |
| Sponsor: | MSD |
| Start Date: | September 2020 |
| Primary Completion Date: | February 2023 |
| Study Completion Date: | October 2026 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Protocol Plain Language Summary – English |
| Country | Location |
|---|---|
| Australia, New South Wales | Macquarie University, New South Wales, Australia, 2109 |
| Australia, Victoria | Box Hill, Victoria, Australia, 3128 |
| Australia, Victoria | Frankston, Victoria, Australia, 3199 |
| Belgium, Antwerpen | Wilrijk, Antwerpen, Belgium, 2610 |
| Belgium, Hainaut | Charleroi, Hainaut, Belgium, 6000 |
| Belgium, Liege | Liège, Liege, Belgium, 4000 |
| Belgium, Oost-Vlaanderen | Gent, Oost-Vlaanderen, Belgium, 9000 |
| Belgium, Vlaams-Brabant | Leuven, Vlaams-Brabant, Belgium, 3000 |
| Greece, Attiki | Athens, Attiki, Greece, 115 28 |
| Greece, Attiki | Chaidari, Attiki, Greece, 12 462 |
| Greece, Thessalia | Larissa, Thessalia, Greece, 411 10 |
| Ireland, Cork | Cork, Ireland, T12 DC4A |
| Ireland, Dublin | Dublin, Ireland, D24 NR0A |
| Israel, N/A | Beer Sheva, N/A, Israel, 8410101 |
| Israel, N/A | Haifa, N/A, Israel, 3109601 |
| Israel, N/A | Petach Tikva, N/A, Israel, 4941492 |
| Israel, N/A | Tel Aviv, N/A, Israel, 6423906 |
| Netherlands, Limburg | Maastricht, Limburg, Netherlands, 6202AZ |
| Netherlands, Noord-Holland | Amsterdam, Noord-Holland, Netherlands, 1066 CX |
| Netherlands, Overijssel | Zwolle, Overijssel, Netherlands, 8025 AB |
| Netherlands, Utrecht | Utrecht, Netherlands, 3584 CX |
| Netherlands, Zuid-Holland | Rotterdam, Zuid-Holland, Netherlands, 3015 GD |
| Russian Federation, Moskva | Moscow, Moskva, Russian Federation, 117997 |
| Russian Federation, Moskva | Moscow, Moskva, Russian Federation, 129090 |
| Russian Federation, Sankt-Peterburg | Saint Petersburg, Sankt-Peterburg, Russian Federation, 197758 |
| Russian Federation, Sankt-Peterburg | Saint-Petersburg, Sankt-Peterburg, Russian Federation, 197758 |
| United Kingdom, England | London, England, United Kingdom, NW3 2QG |
| United Kingdom, London, City of | London, London, City of, United Kingdom, W6 8RF |
| United Kingdom, Nottingham | Nottingham, United Kingdom, NG5 1PB |
| United Kingdom, Oxfordshire | Oxford, Oxfordshire, United Kingdom, OX3 7LE |
| United States, DC | Washinton, DC, United States, 20007 |
| United States, FL | Miami, FL, United States, 33136 |
| United States, KY | Louisville, KY, United States, 40207 |
| United States, MD | Baltimore, MD, United States, 21237 |
| United States, NE | Lincoln, NE, United States, 68510 |
| United States, NE | Omaha, NE, United States, 68130 |
| United States, NY | Albany, NY, United States, 12206 |
| United States, NY | Buffalo, NY, United States, 14263 |
| United States, PA | Philadelphia, PA, United States, 19111 |
| United States, SD | Sioux Falls, SD, United States, 57104 |
| United States, TN | Germantown, TN, United States, 38138 |
| United States, TN | Nashville, TN, United States, 37209 |
| United States, TX | Dallas, TX, United States, 75390 |
| United States, TX | Temple, TX, United States, 76508 |
| United States, UT | Salt Lake City, UT, United States, 84112 |
| United States, VA | Fairfax, VA, United States, 22031 |
| United States, VA | Roanoke, VA, United States, 24014 |
| United States, WA | Kennewick, WA, United States, 99336 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company